nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—CYP1A2—Dacarbazine—muscle cancer	0.191	0.365	CbGbCtD
Estropipate—ALB—Methotrexate—muscle cancer	0.103	0.197	CbGbCtD
Estropipate—CYP1A2—Etoposide—muscle cancer	0.0934	0.179	CbGbCtD
Estropipate—CYP3A4—Vincristine—muscle cancer	0.0534	0.102	CbGbCtD
Estropipate—CYP3A4—Etoposide—muscle cancer	0.0489	0.0935	CbGbCtD
Estropipate—CYP3A4—Doxorubicin—muscle cancer	0.0334	0.0638	CbGbCtD
Estropipate—SHBG—hindlimb—muscle cancer	0.00607	0.253	CbGeAlD
Estropipate—Vaginal inflammation—Methotrexate—muscle cancer	0.00213	0.0047	CcSEcCtD
Estropipate—Pulmonary embolism—Methotrexate—muscle cancer	0.00213	0.0047	CcSEcCtD
Estropipate—Breast pain—Doxorubicin—muscle cancer	0.00211	0.00467	CcSEcCtD
Estropipate—Amenorrhoea—Doxorubicin—muscle cancer	0.0021	0.00463	CcSEcCtD
Estropipate—Cardiovascular disorder—Doxorubicin—muscle cancer	0.0021	0.00463	CcSEcCtD
Estropipate—Jaundice cholestatic—Doxorubicin—muscle cancer	0.0021	0.00463	CcSEcCtD
Estropipate—Cystitis noninfective—Methotrexate—muscle cancer	0.00208	0.00459	CcSEcCtD
Estropipate—Cystitis—Methotrexate—muscle cancer	0.00206	0.00454	CcSEcCtD
Estropipate—Cardiac disorder—Vincristine—muscle cancer	0.00204	0.00452	CcSEcCtD
Estropipate—Bone disorder—Doxorubicin—muscle cancer	0.00204	0.00451	CcSEcCtD
Estropipate—Hypocalcaemia—Doxorubicin—muscle cancer	0.00201	0.00445	CcSEcCtD
Estropipate—Cough increased—Doxorubicin—muscle cancer	0.00201	0.00445	CcSEcCtD
Estropipate—Vaginal infection—Methotrexate—muscle cancer	0.00201	0.00444	CcSEcCtD
Estropipate—Angiopathy—Vincristine—muscle cancer	0.002	0.00442	CcSEcCtD
Estropipate—Infestation NOS—Etoposide—muscle cancer	0.00199	0.00439	CcSEcCtD
Estropipate—Infestation—Etoposide—muscle cancer	0.00199	0.00439	CcSEcCtD
Estropipate—Mediastinal disorder—Vincristine—muscle cancer	0.00199	0.00439	CcSEcCtD
Estropipate—Acute coronary syndrome—Etoposide—muscle cancer	0.00196	0.00433	CcSEcCtD
Estropipate—Myocardial infarction—Etoposide—muscle cancer	0.00195	0.0043	CcSEcCtD
Estropipate—Neuropathy peripheral—Etoposide—muscle cancer	0.00195	0.0043	CcSEcCtD
Estropipate—Alopecia—Vincristine—muscle cancer	0.00195	0.0043	CcSEcCtD
Estropipate—Mental disorder—Vincristine—muscle cancer	0.00193	0.00426	CcSEcCtD
Estropipate—Bladder pain—Methotrexate—muscle cancer	0.00192	0.00425	CcSEcCtD
Estropipate—Neoplasm—Methotrexate—muscle cancer	0.00192	0.00425	CcSEcCtD
Estropipate—Inflammation—Doxorubicin—muscle cancer	0.0019	0.0042	CcSEcCtD
Estropipate—Hepatobiliary disease—Etoposide—muscle cancer	0.00188	0.00415	CcSEcCtD
Estropipate—Musculoskeletal pain—Doxorubicin—muscle cancer	0.00187	0.00412	CcSEcCtD
Estropipate—Back pain—Vincristine—muscle cancer	0.00186	0.0041	CcSEcCtD
Estropipate—Pulmonary embolism—Doxorubicin—muscle cancer	0.00184	0.00407	CcSEcCtD
Estropipate—Vaginal inflammation—Doxorubicin—muscle cancer	0.00184	0.00407	CcSEcCtD
Estropipate—Myalgia—Dactinomycin—muscle cancer	0.00183	0.00404	CcSEcCtD
Estropipate—Cystitis noninfective—Doxorubicin—muscle cancer	0.0018	0.00398	CcSEcCtD
Estropipate—Thrombophlebitis—Methotrexate—muscle cancer	0.00179	0.00394	CcSEcCtD
Estropipate—Cystitis—Doxorubicin—muscle cancer	0.00178	0.00393	CcSEcCtD
Estropipate—Oedema—Dactinomycin—muscle cancer	0.00175	0.00387	CcSEcCtD
Estropipate—Fluid retention—Doxorubicin—muscle cancer	0.00175	0.00387	CcSEcCtD
Estropipate—Infection—Dactinomycin—muscle cancer	0.00174	0.00384	CcSEcCtD
Estropipate—Vaginal infection—Doxorubicin—muscle cancer	0.00174	0.00384	CcSEcCtD
Estropipate—Vertigo—Vincristine—muscle cancer	0.00172	0.00381	CcSEcCtD
Estropipate—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00169	0.00374	CcSEcCtD
Estropipate—Erythema multiforme—Etoposide—muscle cancer	0.00169	0.00373	CcSEcCtD
Estropipate—Eye disorder—Etoposide—muscle cancer	0.00167	0.00368	CcSEcCtD
Estropipate—Neoplasm—Doxorubicin—muscle cancer	0.00167	0.00368	CcSEcCtD
Estropipate—Bladder pain—Doxorubicin—muscle cancer	0.00167	0.00368	CcSEcCtD
Estropipate—Cardiac disorder—Etoposide—muscle cancer	0.00166	0.00366	CcSEcCtD
Estropipate—Myalgia—Vincristine—muscle cancer	0.00163	0.00361	CcSEcCtD
Estropipate—Visual disturbance—Methotrexate—muscle cancer	0.00163	0.0036	CcSEcCtD
Estropipate—Angiopathy—Etoposide—muscle cancer	0.00162	0.00358	CcSEcCtD
Estropipate—Hypertonia—Doxorubicin—muscle cancer	0.00162	0.00357	CcSEcCtD
Estropipate—Immune system disorder—Etoposide—muscle cancer	0.00161	0.00356	CcSEcCtD
Estropipate—Mediastinal disorder—Etoposide—muscle cancer	0.00161	0.00355	CcSEcCtD
Estropipate—Anaphylactoid reaction—Methotrexate—muscle cancer	0.0016	0.00353	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.0016	0.00353	CcSEcCtD
Estropipate—Alopecia—Etoposide—muscle cancer	0.00158	0.00348	CcSEcCtD
Estropipate—Cerebrovascular accident—Methotrexate—muscle cancer	0.00158	0.00348	CcSEcCtD
Estropipate—Oedema—Vincristine—muscle cancer	0.00157	0.00346	CcSEcCtD
Estropipate—Anaphylactic shock—Vincristine—muscle cancer	0.00157	0.00346	CcSEcCtD
Estropipate—Infection—Vincristine—muscle cancer	0.00156	0.00344	CcSEcCtD
Estropipate—Thrombophlebitis—Doxorubicin—muscle cancer	0.00155	0.00341	CcSEcCtD
Estropipate—Nervous system disorder—Vincristine—muscle cancer	0.00154	0.00339	CcSEcCtD
Estropipate—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00153	0.00338	CcSEcCtD
Estropipate—Fatigue—Dactinomycin—muscle cancer	0.00151	0.00334	CcSEcCtD
Estropipate—Back pain—Etoposide—muscle cancer	0.0015	0.00332	CcSEcCtD
Estropipate—Pain—Dactinomycin—muscle cancer	0.0015	0.00331	CcSEcCtD
Estropipate—Muscle spasms—Etoposide—muscle cancer	0.00149	0.0033	CcSEcCtD
Estropipate—Irritability—Methotrexate—muscle cancer	0.00148	0.00326	CcSEcCtD
Estropipate—Mood swings—Methotrexate—muscle cancer	0.00146	0.00323	CcSEcCtD
Estropipate—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00143	0.00316	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00143	0.00315	CcSEcCtD
Estropipate—Insomnia—Vincristine—muscle cancer	0.00142	0.00313	CcSEcCtD
Estropipate—Paraesthesia—Vincristine—muscle cancer	0.00141	0.0031	CcSEcCtD
Estropipate—Dermatitis bullous—Doxorubicin—muscle cancer	0.0014	0.00309	CcSEcCtD
Estropipate—ESR2—smooth muscle tissue—muscle cancer	0.0014	0.0584	CbGeAlD
Estropipate—Breast disorder—Methotrexate—muscle cancer	0.0014	0.00308	CcSEcCtD
Estropipate—Vertigo—Etoposide—muscle cancer	0.0014	0.00308	CcSEcCtD
Estropipate—Purpura—Doxorubicin—muscle cancer	0.00139	0.00307	CcSEcCtD
Estropipate—Body temperature increased—Dactinomycin—muscle cancer	0.00139	0.00306	CcSEcCtD
Estropipate—Abdominal pain—Dactinomycin—muscle cancer	0.00139	0.00306	CcSEcCtD
Estropipate—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00138	0.00305	CcSEcCtD
Estropipate—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00137	0.00302	CcSEcCtD
Estropipate—Cough—Etoposide—muscle cancer	0.00136	0.00299	CcSEcCtD
Estropipate—Gastrointestinal disorder—Vincristine—muscle cancer	0.00135	0.00299	CcSEcCtD
Estropipate—Fatigue—Vincristine—muscle cancer	0.00135	0.00298	CcSEcCtD
Estropipate—ESR2—renal system—muscle cancer	0.00135	0.0562	CbGeAlD
Estropipate—Pain—Vincristine—muscle cancer	0.00134	0.00296	CcSEcCtD
Estropipate—Constipation—Vincristine—muscle cancer	0.00134	0.00296	CcSEcCtD
Estropipate—Pain in extremity—Doxorubicin—muscle cancer	0.00134	0.00296	CcSEcCtD
Estropipate—Asthma—Methotrexate—muscle cancer	0.00134	0.00295	CcSEcCtD
Estropipate—Migraine—Doxorubicin—muscle cancer	0.00132	0.00291	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00131	0.0029	CcSEcCtD
Estropipate—Pancreatitis—Methotrexate—muscle cancer	0.00131	0.00289	CcSEcCtD
Estropipate—Hypersensitivity—Dactinomycin—muscle cancer	0.00129	0.00285	CcSEcCtD
Estropipate—Abdominal discomfort—Methotrexate—muscle cancer	0.00128	0.00283	CcSEcCtD
Estropipate—Gastrointestinal pain—Vincristine—muscle cancer	0.00128	0.00283	CcSEcCtD
Estropipate—Anaphylactic shock—Etoposide—muscle cancer	0.00127	0.0028	CcSEcCtD
Estropipate—Mood swings—Doxorubicin—muscle cancer	0.00127	0.0028	CcSEcCtD
Estropipate—Infection—Etoposide—muscle cancer	0.00126	0.00278	CcSEcCtD
Estropipate—Asthenia—Dactinomycin—muscle cancer	0.00126	0.00278	CcSEcCtD
Estropipate—Dysuria—Methotrexate—muscle cancer	0.00125	0.00276	CcSEcCtD
Estropipate—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00124	0.00274	CcSEcCtD
Estropipate—Abdominal pain—Vincristine—muscle cancer	0.00124	0.00273	CcSEcCtD
Estropipate—Body temperature increased—Vincristine—muscle cancer	0.00124	0.00273	CcSEcCtD
Estropipate—Skin disorder—Etoposide—muscle cancer	0.00123	0.00272	CcSEcCtD
Estropipate—ESR1—embryo—muscle cancer	0.00122	0.0509	CbGeAlD
Estropipate—Breast disorder—Doxorubicin—muscle cancer	0.00121	0.00267	CcSEcCtD
Estropipate—Diarrhoea—Dactinomycin—muscle cancer	0.0012	0.00265	CcSEcCtD
Estropipate—Infestation NOS—Methotrexate—muscle cancer	0.00119	0.00263	CcSEcCtD
Estropipate—Infestation—Methotrexate—muscle cancer	0.00119	0.00263	CcSEcCtD
Estropipate—Depression—Methotrexate—muscle cancer	0.00119	0.00262	CcSEcCtD
Estropipate—Abdominal distension—Doxorubicin—muscle cancer	0.00116	0.00257	CcSEcCtD
Estropipate—Asthma—Doxorubicin—muscle cancer	0.00116	0.00255	CcSEcCtD
Estropipate—Influenza—Doxorubicin—muscle cancer	0.00116	0.00255	CcSEcCtD
Estropipate—Hypersensitivity—Vincristine—muscle cancer	0.00115	0.00255	CcSEcCtD
Estropipate—Paraesthesia—Etoposide—muscle cancer	0.00114	0.00252	CcSEcCtD
Estropipate—Pancreatitis—Doxorubicin—muscle cancer	0.00113	0.0025	CcSEcCtD
Estropipate—SLC22A1—renal system—muscle cancer	0.00113	0.0471	CbGeAlD
Estropipate—Somnolence—Etoposide—muscle cancer	0.00113	0.00249	CcSEcCtD
Estropipate—Hepatobiliary disease—Methotrexate—muscle cancer	0.00113	0.00249	CcSEcCtD
Estropipate—Asthenia—Vincristine—muscle cancer	0.00112	0.00248	CcSEcCtD
Estropipate—Vomiting—Dactinomycin—muscle cancer	0.00111	0.00246	CcSEcCtD
Estropipate—Rash—Dactinomycin—muscle cancer	0.0011	0.00244	CcSEcCtD
Estropipate—Gastrointestinal disorder—Etoposide—muscle cancer	0.00109	0.00242	CcSEcCtD
Estropipate—Fatigue—Etoposide—muscle cancer	0.00109	0.00241	CcSEcCtD
Estropipate—Constipation—Etoposide—muscle cancer	0.00108	0.0024	CcSEcCtD
Estropipate—Pain—Etoposide—muscle cancer	0.00108	0.0024	CcSEcCtD
Estropipate—Dysuria—Doxorubicin—muscle cancer	0.00108	0.00239	CcSEcCtD
Estropipate—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00107	0.00237	CcSEcCtD
Estropipate—Diarrhoea—Vincristine—muscle cancer	0.00107	0.00237	CcSEcCtD
Estropipate—Pharyngitis—Methotrexate—muscle cancer	0.00106	0.00234	CcSEcCtD
Estropipate—Weight increased—Doxorubicin—muscle cancer	0.00105	0.00232	CcSEcCtD
Estropipate—Hyperglycaemia—Doxorubicin—muscle cancer	0.00104	0.0023	CcSEcCtD
Estropipate—Nausea—Dactinomycin—muscle cancer	0.00104	0.0023	CcSEcCtD
Estropipate—Gastrointestinal pain—Etoposide—muscle cancer	0.00104	0.00229	CcSEcCtD
Estropipate—Dizziness—Vincristine—muscle cancer	0.00104	0.00229	CcSEcCtD
Estropipate—Infestation NOS—Doxorubicin—muscle cancer	0.00103	0.00228	CcSEcCtD
Estropipate—Infestation—Doxorubicin—muscle cancer	0.00103	0.00228	CcSEcCtD
Estropipate—Visual impairment—Methotrexate—muscle cancer	0.00103	0.00228	CcSEcCtD
Estropipate—Erythema multiforme—Methotrexate—muscle cancer	0.00101	0.00223	CcSEcCtD
Estropipate—Neuropathy peripheral—Doxorubicin—muscle cancer	0.00101	0.00223	CcSEcCtD
Estropipate—Urticaria—Etoposide—muscle cancer	0.00101	0.00223	CcSEcCtD
Estropipate—Abdominal pain—Etoposide—muscle cancer	0.001	0.00221	CcSEcCtD
Estropipate—Body temperature increased—Etoposide—muscle cancer	0.001	0.00221	CcSEcCtD
Estropipate—Eye disorder—Methotrexate—muscle cancer	0.000999	0.00221	CcSEcCtD
Estropipate—Vomiting—Vincristine—muscle cancer	0.000995	0.0022	CcSEcCtD
Estropipate—Cardiac disorder—Methotrexate—muscle cancer	0.000992	0.00219	CcSEcCtD
Estropipate—SHBG—bone marrow—muscle cancer	0.000989	0.0413	CbGeAlD
Estropipate—Rash—Vincristine—muscle cancer	0.000987	0.00218	CcSEcCtD
Estropipate—Dermatitis—Vincristine—muscle cancer	0.000986	0.00218	CcSEcCtD
Estropipate—Headache—Vincristine—muscle cancer	0.000981	0.00217	CcSEcCtD
Estropipate—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000975	0.00215	CcSEcCtD
Estropipate—ESR2—vagina—muscle cancer	0.000974	0.0407	CbGeAlD
Estropipate—Angiopathy—Methotrexate—muscle cancer	0.00097	0.00214	CcSEcCtD
Estropipate—Sinusitis—Doxorubicin—muscle cancer	0.000968	0.00214	CcSEcCtD
Estropipate—Immune system disorder—Methotrexate—muscle cancer	0.000966	0.00213	CcSEcCtD
Estropipate—Mediastinal disorder—Methotrexate—muscle cancer	0.000964	0.00213	CcSEcCtD
Estropipate—ESR1—smooth muscle tissue—muscle cancer	0.000957	0.04	CbGeAlD
Estropipate—SHBG—vagina—muscle cancer	0.000947	0.0396	CbGeAlD
Estropipate—Alopecia—Methotrexate—muscle cancer	0.000945	0.00209	CcSEcCtD
Estropipate—Mental disorder—Methotrexate—muscle cancer	0.000937	0.00207	CcSEcCtD
Estropipate—Hypersensitivity—Etoposide—muscle cancer	0.000934	0.00206	CcSEcCtD
Estropipate—Erythema—Methotrexate—muscle cancer	0.000931	0.00206	CcSEcCtD
Estropipate—Malnutrition—Methotrexate—muscle cancer	0.000931	0.00206	CcSEcCtD
Estropipate—Nausea—Vincristine—muscle cancer	0.00093	0.00205	CcSEcCtD
Estropipate—Rhinitis—Doxorubicin—muscle cancer	0.000928	0.00205	CcSEcCtD
Estropipate—ESR1—renal system—muscle cancer	0.000921	0.0385	CbGeAlD
Estropipate—Pharyngitis—Doxorubicin—muscle cancer	0.000919	0.00203	CcSEcCtD
Estropipate—Oedema peripheral—Doxorubicin—muscle cancer	0.000912	0.00201	CcSEcCtD
Estropipate—Asthenia—Etoposide—muscle cancer	0.00091	0.00201	CcSEcCtD
Estropipate—Back pain—Methotrexate—muscle cancer	0.0009	0.00199	CcSEcCtD
Estropipate—ESR2—head—muscle cancer	0.0009	0.0376	CbGeAlD
Estropipate—Pruritus—Etoposide—muscle cancer	0.000897	0.00198	CcSEcCtD
Estropipate—Visual impairment—Doxorubicin—muscle cancer	0.000892	0.00197	CcSEcCtD
Estropipate—Erythema multiforme—Doxorubicin—muscle cancer	0.000875	0.00193	CcSEcCtD
Estropipate—ESR2—testis—muscle cancer	0.000869	0.0363	CbGeAlD
Estropipate—Diarrhoea—Etoposide—muscle cancer	0.000868	0.00192	CcSEcCtD
Estropipate—Eye disorder—Doxorubicin—muscle cancer	0.000865	0.00191	CcSEcCtD
Estropipate—Cardiac disorder—Doxorubicin—muscle cancer	0.000859	0.0019	CcSEcCtD
Estropipate—SHBG—testis—muscle cancer	0.000845	0.0353	CbGeAlD
Estropipate—Angiopathy—Doxorubicin—muscle cancer	0.00084	0.00186	CcSEcCtD
Estropipate—Dizziness—Etoposide—muscle cancer	0.000839	0.00185	CcSEcCtD
Estropipate—Immune system disorder—Doxorubicin—muscle cancer	0.000836	0.00185	CcSEcCtD
Estropipate—Vertigo—Methotrexate—muscle cancer	0.000836	0.00185	CcSEcCtD
Estropipate—Mediastinal disorder—Doxorubicin—muscle cancer	0.000834	0.00184	CcSEcCtD
Estropipate—Alopecia—Doxorubicin—muscle cancer	0.000818	0.00181	CcSEcCtD
Estropipate—SLC22A1—vagina—muscle cancer	0.000817	0.0341	CbGeAlD
Estropipate—Cough—Methotrexate—muscle cancer	0.000812	0.00179	CcSEcCtD
Estropipate—Mental disorder—Doxorubicin—muscle cancer	0.000811	0.00179	CcSEcCtD
Estropipate—Vomiting—Etoposide—muscle cancer	0.000806	0.00178	CcSEcCtD
Estropipate—Erythema—Doxorubicin—muscle cancer	0.000806	0.00178	CcSEcCtD
Estropipate—Malnutrition—Doxorubicin—muscle cancer	0.000806	0.00178	CcSEcCtD
Estropipate—Rash—Etoposide—muscle cancer	0.0008	0.00177	CcSEcCtD
Estropipate—Dermatitis—Etoposide—muscle cancer	0.000799	0.00176	CcSEcCtD
Estropipate—Headache—Etoposide—muscle cancer	0.000794	0.00175	CcSEcCtD
Estropipate—Flatulence—Doxorubicin—muscle cancer	0.000794	0.00175	CcSEcCtD
Estropipate—Myalgia—Methotrexate—muscle cancer	0.000792	0.00175	CcSEcCtD
Estropipate—Arthralgia—Methotrexate—muscle cancer	0.000792	0.00175	CcSEcCtD
Estropipate—Tension—Doxorubicin—muscle cancer	0.000791	0.00175	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000787	0.00174	CcSEcCtD
Estropipate—Nervousness—Doxorubicin—muscle cancer	0.000783	0.00173	CcSEcCtD
Estropipate—Back pain—Doxorubicin—muscle cancer	0.00078	0.00172	CcSEcCtD
Estropipate—Muscle spasms—Doxorubicin—muscle cancer	0.000775	0.00171	CcSEcCtD
Estropipate—Anaphylactic shock—Methotrexate—muscle cancer	0.00076	0.00168	CcSEcCtD
Estropipate—SLC22A1—head—muscle cancer	0.000755	0.0315	CbGeAlD
Estropipate—Infection—Methotrexate—muscle cancer	0.000755	0.00167	CcSEcCtD
Estropipate—Nausea—Etoposide—muscle cancer	0.000753	0.00166	CcSEcCtD
Estropipate—Nervous system disorder—Methotrexate—muscle cancer	0.000745	0.00165	CcSEcCtD
Estropipate—Skin disorder—Methotrexate—muscle cancer	0.000738	0.00163	CcSEcCtD
Estropipate—Vertigo—Doxorubicin—muscle cancer	0.000724	0.0016	CcSEcCtD
Estropipate—Palpitations—Doxorubicin—muscle cancer	0.000712	0.00157	CcSEcCtD
Estropipate—CYP1A2—renal system—muscle cancer	0.00071	0.0297	CbGeAlD
Estropipate—Cough—Doxorubicin—muscle cancer	0.000703	0.00155	CcSEcCtD
Estropipate—ALB—testis—muscle cancer	0.000698	0.0292	CbGeAlD
Estropipate—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000692	0.00153	CcSEcCtD
Estropipate—Insomnia—Methotrexate—muscle cancer	0.000687	0.00152	CcSEcCtD
Estropipate—Arthralgia—Doxorubicin—muscle cancer	0.000686	0.00152	CcSEcCtD
Estropipate—Myalgia—Doxorubicin—muscle cancer	0.000686	0.00152	CcSEcCtD
Estropipate—Anxiety—Doxorubicin—muscle cancer	0.000684	0.00151	CcSEcCtD
Estropipate—Paraesthesia—Methotrexate—muscle cancer	0.000682	0.00151	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000681	0.00151	CcSEcCtD
Estropipate—Somnolence—Methotrexate—muscle cancer	0.000675	0.00149	CcSEcCtD
Estropipate—Dyspepsia—Methotrexate—muscle cancer	0.000669	0.00148	CcSEcCtD
Estropipate—ESR1—vagina—muscle cancer	0.000667	0.0279	CbGeAlD
Estropipate—Oedema—Doxorubicin—muscle cancer	0.000658	0.00145	CcSEcCtD
Estropipate—Anaphylactic shock—Doxorubicin—muscle cancer	0.000658	0.00145	CcSEcCtD
Estropipate—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000656	0.00145	CcSEcCtD
Estropipate—Fatigue—Methotrexate—muscle cancer	0.000655	0.00145	CcSEcCtD
Estropipate—Infection—Doxorubicin—muscle cancer	0.000653	0.00144	CcSEcCtD
Estropipate—Pain—Methotrexate—muscle cancer	0.00065	0.00143	CcSEcCtD
Estropipate—Nervous system disorder—Doxorubicin—muscle cancer	0.000645	0.00142	CcSEcCtD
Estropipate—Skin disorder—Doxorubicin—muscle cancer	0.000639	0.00141	CcSEcCtD
Estropipate—Gastrointestinal pain—Methotrexate—muscle cancer	0.000621	0.00137	CcSEcCtD
Estropipate—ESR1—head—muscle cancer	0.000616	0.0258	CbGeAlD
Estropipate—Urticaria—Methotrexate—muscle cancer	0.000603	0.00133	CcSEcCtD
Estropipate—Body temperature increased—Methotrexate—muscle cancer	0.0006	0.00133	CcSEcCtD
Estropipate—Abdominal pain—Methotrexate—muscle cancer	0.0006	0.00133	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000599	0.00132	CcSEcCtD
Estropipate—ESR1—testis—muscle cancer	0.000596	0.0249	CbGeAlD
Estropipate—Insomnia—Doxorubicin—muscle cancer	0.000595	0.00131	CcSEcCtD
Estropipate—Paraesthesia—Doxorubicin—muscle cancer	0.000591	0.0013	CcSEcCtD
Estropipate—Somnolence—Doxorubicin—muscle cancer	0.000585	0.00129	CcSEcCtD
Estropipate—Dyspepsia—Doxorubicin—muscle cancer	0.000579	0.00128	CcSEcCtD
Estropipate—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000568	0.00125	CcSEcCtD
Estropipate—Fatigue—Doxorubicin—muscle cancer	0.000567	0.00125	CcSEcCtD
Estropipate—Constipation—Doxorubicin—muscle cancer	0.000562	0.00124	CcSEcCtD
Estropipate—Pain—Doxorubicin—muscle cancer	0.000562	0.00124	CcSEcCtD
Estropipate—Hypersensitivity—Methotrexate—muscle cancer	0.00056	0.00124	CcSEcCtD
Estropipate—Asthenia—Methotrexate—muscle cancer	0.000545	0.0012	CcSEcCtD
Estropipate—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000538	0.00119	CcSEcCtD
Estropipate—Pruritus—Methotrexate—muscle cancer	0.000537	0.00119	CcSEcCtD
Estropipate—Urticaria—Doxorubicin—muscle cancer	0.000523	0.00115	CcSEcCtD
Estropipate—Body temperature increased—Doxorubicin—muscle cancer	0.00052	0.00115	CcSEcCtD
Estropipate—Abdominal pain—Doxorubicin—muscle cancer	0.00052	0.00115	CcSEcCtD
Estropipate—Diarrhoea—Methotrexate—muscle cancer	0.00052	0.00115	CcSEcCtD
Estropipate—CYP3A4—renal system—muscle cancer	0.000514	0.0215	CbGeAlD
Estropipate—Dizziness—Methotrexate—muscle cancer	0.000502	0.00111	CcSEcCtD
Estropipate—Hypersensitivity—Doxorubicin—muscle cancer	0.000485	0.00107	CcSEcCtD
Estropipate—Vomiting—Methotrexate—muscle cancer	0.000483	0.00107	CcSEcCtD
Estropipate—Rash—Methotrexate—muscle cancer	0.000479	0.00106	CcSEcCtD
Estropipate—Dermatitis—Methotrexate—muscle cancer	0.000478	0.00106	CcSEcCtD
Estropipate—Headache—Methotrexate—muscle cancer	0.000476	0.00105	CcSEcCtD
Estropipate—Asthenia—Doxorubicin—muscle cancer	0.000472	0.00104	CcSEcCtD
Estropipate—Pruritus—Doxorubicin—muscle cancer	0.000465	0.00103	CcSEcCtD
Estropipate—Nausea—Methotrexate—muscle cancer	0.000451	0.000997	CcSEcCtD
Estropipate—Diarrhoea—Doxorubicin—muscle cancer	0.00045	0.000994	CcSEcCtD
Estropipate—Dizziness—Doxorubicin—muscle cancer	0.000435	0.000961	CcSEcCtD
Estropipate—Vomiting—Doxorubicin—muscle cancer	0.000418	0.000924	CcSEcCtD
Estropipate—Rash—Doxorubicin—muscle cancer	0.000415	0.000916	CcSEcCtD
Estropipate—Dermatitis—Doxorubicin—muscle cancer	0.000414	0.000915	CcSEcCtD
Estropipate—Headache—Doxorubicin—muscle cancer	0.000412	0.00091	CcSEcCtD
Estropipate—Nausea—Doxorubicin—muscle cancer	0.000391	0.000863	CcSEcCtD
